Abbott India Analysis

June 14, 2020
Category: video


Update on Pharma Funds investment status. Stops have not moved while NAV’s dropped. The risk remains at 2%. UTI Pharma has done well among the peers. How a small deviation in the holdings helps Mutual Fund Schemes to outperform and will such trend continue? Which funds have the holdings of upcoming stocks? Only DSP having most of the stocks is a surprise.

Abbott is in a long term bullish trend while going into a short term correction. Those holding the stock can exit now and buy later.